About Avacta Group Plc
Avacta Group plc is a biotechnology company. The Company is a developer of Affimer bio therapeutics and research reagents. Its segments include Animal Health, which provides tools and contract services to assist diagnosis of conditions in animals to enable treatment for veterinarians, and Life Sciences, which provides reagents and arrays for diagnostics, drug and biomarker discovery in biotech research and development. Its in-house programs include Oncology, which is engaged in developing combination therapies combining multiple immune checkpoint inhibitors by making bi- and tri-specific Affimer constructs, and Blood clotting disorders, which allows Affimer therapeutics to generate the modulate blood clot formation with the potential for anti-thrombotic, as well as wound healing therapies. It focuses on its Affimer technology, which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: LON
- Symbol: AVCT
- Previous Close: $0.85
- 50 Day Moving Average: $70.92
- 200 Day Moving Average: $85.71
- 52-Week Range: GBX 67 - GBX 119.50
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Market Cap: $44.30M
- Outstanding Shares: 65,146,000
Consensus Ratings for Avacta Group Plc (LON:AVCT) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 200|
Analysts' Ratings History for Avacta Group Plc (LON:AVCT)
(Data available from 2/21/2015 forward)
|1/20/2017||FinnCap||Reiterated Rating||Corporate||GBX 200|
|8/1/2016||Numis Securities Ltd||Reiterated Rating||Buy|
Earnings History for Avacta Group Plc (LON:AVCT)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Avacta Group Plc (LON:AVCT)
Current Year EPS Consensus Estimate: $-5.37 EPS
Dividend History for Avacta Group Plc (LON:AVCT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Avacta Group Plc (LON:AVCT)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/21/2016||Mike Owen||Insider||Buy||7,763||GBX 90||£6,986.70|
|7/7/2016||Albin,Michael Scott||Insider||Buy||3,393||GBX 92||£3,121.56|
|4/29/2016||Slater ,Craig||Insider||Buy||2,222||GBX 113||£2,510.86|
|4/6/2016||Albin,Michael Scott||Insider||Buy||899||GBX 116||£1,042.84|
Latest Headlines for Avacta Group Plc (LON:AVCT)
What is Avacta Group Plc's stock symbol?
Avacta Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "AVCT."
Where is Avacta Group Plc's stock going? Where will Avacta Group Plc's stock price be in 2017?
1 analysts have issued 1 year price targets for Avacta Group Plc's stock. Their forecasts range from GBX 200 to GBX 200. On average, they anticipate Avacta Group Plc's share price to reach GBX 200 in the next twelve months.
How do I buy Avacta Group Plc stock?
Shares of Avacta Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Avacta Group Plc stock cost?
One share of Avacta Group Plc stock can currently be purchased for approximately GBX 68.